Although removing the drugs from the coverage list will save the state money in the short-term, Stewart said she worried it will cost more in the long run as more people develop other health conditions related to obesity
The relevant analytical framework follows the ICH Q6B guidance for peptide drug substances, which covers reporting of identity, purity, content, and impurity profiles
Stay consistent with injections
This is why who you work with matters
Clinical trials show average weight loss of 50+ pounds over 3-6 months, with continued gradual loss possible over longer treatment periods
Image Credit: Kokosha Yuliya / Shutterstock.com A recent study published in Obesities examines how the effectiveness of weight-loss medications may depend on the patients adherence to their treatment protocol in unsubsidized lifestyle-supported, pharmacological digital weight-loss services